LIPO
Lipella Pharmaceuticals Inc.Company with tickers: LIPO
CIK
1347242
CUSIP
53630L209
Shares Outstanding
4,620,837
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-04-03 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 536,959 |
| 2025-04-03 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 4,060 |
| 2025-04-03 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 125,833 |
| 2025-04-03 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 28,924 |
| 2025-03-13 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 4,060 |
| 2025-03-13 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 10,326 |
| 2025-03-10 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 84,700 |
| 2025-03-10 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 28,924 |
| 2025-02-28 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 125,833 |
| 2025-02-28 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 441,933 |
| 2025-01-15 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 303,041 |
| 2025-01-15 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 11,795 |
| 2025-01-15 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 85,421 |
| 2024-12-31 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 11,795 |
| 2024-12-31 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 42,933 |
| 2024-12-23 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 85,421 |
| 2024-12-23 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 260,108 |
| 2024-05-14 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Buy | 10,000 |
| 2024-03-19 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Buy | 25,000 |
| 2024-03-18 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Buy | 30,000 |
| 2024-03-15 | Chancellor Michael B | Director, Chief Medical Officer, 10% Owner | Award | 80,000 |
| 2024-03-15 | Birder Lori | Director | Award | 25,000 |
| 2024-03-15 | Kim Byong | Director | Award | 25,000 |
| 2024-03-15 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Award | 80,000 |
| 2024-03-15 | Johnston Douglas | Chief Financial Officer | Award | 50,000 |
| 2024-03-15 | Pruchnic Ryan | Director | Award | 25,000 |
| 2024-03-15 | Yoshimura Naoki | Director | Award | 25,000 |
| 2024-03-15 | Cohen Daniel R | Director | Award | 25,000 |
| 2024-03-13 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Award | 144,906 |
| 2024-03-13 | Chancellor Michael B | Director, Chief Medical Officer, 10% Owner | Award | 144,906 |
| 2023-06-17 | Birder Lori | Director | Other | 0 |
| 2023-06-16 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Award | 79,500 |
| 2023-06-16 | Chancellor Michael B | Director, Chief Medical Officer, 10% Owner | Award | 79,500 |
| 2023-06-16 | Yoshimura Naoki | Director | Award | 25,000 |
| 2023-06-16 | Cohen Daniel R | Director | Award | 25,000 |
| 2023-06-16 | Kim Byong | Director | Award | 25,000 |
| 2023-06-16 | Johnston Douglas | Chief Financial Officer | Award | 50,000 |
| 2023-06-16 | Battleman David S. | Director | Award | 25,000 |
| 2023-06-16 | Pruchnic Ryan | Director | Award | 25,000 |
| 2023-03-21 | Cohen Daniel R | Director | Other | 0 |
| 2022-12-22 | Chancellor Michael B | Director, Chief Medical Officer, 10% Owner | Other | 22,950 |
| 2022-12-19 | Chancellor Michael B | Director, Chief Medical Officer, 10% Owner | Other | 0 |
| 2022-12-19 | Chancellor Michael B | Director, Chief Medical Officer, 10% Owner | Other | 0 |
| 2022-12-19 | Chancellor Michael B | Director, Chief Medical Officer, 10% Owner | Other | 0 |
| 2022-12-19 | Chancellor Michael B | Director, Chief Medical Officer, 10% Owner | Other | 709,780 |
| 2022-12-19 | Chancellor Michael B | Director, Chief Medical Officer, 10% Owner | Other | 0 |
| 2022-12-19 | Chancellor Michael B | Director, Chief Medical Officer, 10% Owner | Other | 0 |
| 2022-12-19 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 0 |
| 2022-12-19 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 0 |
| 2022-12-19 | Battleman David S. | Director | Other | 0 |
| 2022-12-19 | Battleman David S. | Director | Other | 0 |
| 2022-12-19 | Battleman David S. | Director | Other | 0 |
| 2022-12-19 | Yoshimura Naoki | Director | Other | 0 |
| 2022-12-19 | Yoshimura Naoki | Director | Other | 0 |
| 2022-12-19 | Kim Byong | Director | Other | 0 |
| 2022-12-19 | Johnston Douglas | Chief Financial Officer | Other | 0 |
| 2022-12-19 | Battleman David S. | Director | Other | 0 |
| 2022-12-19 | Battleman David S. | Director | Other | 0 |
| 2022-12-19 | Battleman David S. | Director | Other | 0 |
| 2022-12-19 | Pruchnic Ryan | Director | Other | 0 |
| 2022-12-19 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 0 |
| 2022-12-19 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 688,941 |
| 2022-12-19 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 0 |
| 2022-12-19 | Kaufman Jonathan H | Director, See remarks below., 10% Owner | Other | 0 |